Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...

Next phase patient experience focuses on clear communication and care coordination to improve satisfaction and outcomes in hospitals.

CEOs wish list for meaningful healthcare plan highlights reimbursement stability, administrative burden, and workforce sustainability as top priorities.

Cancer research continues to evolve as scientists strive to unravel the complexities of tumor biology, molecular signaling, and metabolic adaptations.